These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9569449)

  • 1. Health effects classification and its role in the derivation of minimal risk levels: neurological effects.
    Chou CH; Williams-Johnson M
    Toxicol Ind Health; 1998; 14(3):455-71. PubMed ID: 9569449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating toxicologic end points to derive minimal risk levels for hazardous substances.
    Chou CH; Williams M; Jones D; De Rosa CT
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):71-5. PubMed ID: 12018018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health effects classification and its role in the derivation of minimal risk levels: renal effects.
    Chou CH; Pohl HR
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):202-8. PubMed ID: 15921839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health effects classification and its role in the derivation of minimal risk levels: developmental effects.
    Pohl HR; Smith-Simon C; Hicks H
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):55-60. PubMed ID: 9784433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health effects classification and its role in the derivation of minimal risk levels: hepatic effects.
    Pohl HR; Chou CH
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):161-71. PubMed ID: 15869832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health effects classification and its role in the derivation of minimal risk levels: reproductive and endocrine effects.
    Pohl HR; Luukinen B; Holler JS
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):209-17. PubMed ID: 15921838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health effects classification and its role in the derivation of minimal risk levels: immunological effects.
    Abadin HG; Chou CH; Llados FT
    Regul Toxicol Pharmacol; 2007 Apr; 47(3):249-56. PubMed ID: 17194513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations and procedures in the derivation of ATSDR minimal risk levels.
    Wheeler JS; Chou S
    Vaccine; 2002 May; 20 Suppl 3():S51-5. PubMed ID: 12184367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical risk assessment and uncertainty associated with extrapolation across exposure duration.
    Pohl HR; Chou CH; Ruiz P; Holler JS
    Regul Toxicol Pharmacol; 2010 Jun; 57(1):18-23. PubMed ID: 19944126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public health guidance values for chemical mixtures: current practice and future directions.
    Pohl HR; Hansen H; Chou CH
    Regul Toxicol Pharmacol; 1997 Dec; 26(3):322-9. PubMed ID: 9441922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilizing uncertainty factors in minimal risk levels derivation.
    Pohl HR; Abadin HG
    Regul Toxicol Pharmacol; 1995 Oct; 22(2):180-8. PubMed ID: 8577953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Great lakes research--important human health findings and their impact on ATSDR's Superfund research program.
    Hicks HE; De Rosa CT
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):49-61. PubMed ID: 12018016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of hematological effects in the development of minimal risk levels.
    Abadin HG; Murray HE; Wheeler JS
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):61-6. PubMed ID: 9784434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATSDR evaluation of health effects of chemicals. V. Xylenes: health effects, toxicokinetics, human exposure, and environmental fate.
    Fay M; Eisenmann C; Diwan S; de Rosa C
    Toxicol Ind Health; 1998; 14(5):571-781. PubMed ID: 9782568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of chemical mixtures in public health practice.
    de Rosa CT; El-Masri HA; Pohl H; Cibulas W; Mumtaz MM
    J Toxicol Environ Health B Crit Rev; 2004; 7(5):339-50. PubMed ID: 15371239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ATSDR's MRL and EPA's RfCs/RfDs: Similarities, Differences, and Rationales.
    Przybyla J; Buser MC; Abadin HG; Pohl HR
    J Toxicol Pharmacol; 2020 Oct; 4(1):1-13. PubMed ID: 37384327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATSDR evaluation of health effects of chemicals. VI. Di(2-ethylhexyl)phthalate. Agency for Toxic Substances and Disease Registry.
    Fay M; Donohue JM; De Rosa C
    Toxicol Ind Health; 1999 Dec; 15(8):651-746. PubMed ID: 10786378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast-feeding exposure of infants to selected pesticides: a public health viewpoint.
    Pohl HR; Tylenda CA
    Toxicol Ind Health; 2000 Feb; 16(2):65-77. PubMed ID: 10798624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future directions of environmental public health research: ATSDR's 2002-2010 agenda for six priority focus areas.
    Spengler RF; Falk H
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):77-83. PubMed ID: 12018019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal Risk Level Derivation for Cadmium: Acute and Intermediate Duration Exposures.
    Faroon O; Keith S; Mumtaz M; Ruiz P
    J Exp Clin Toxicol; 2017 Nov; 1(1):1-12. PubMed ID: 34414376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.